TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol—a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of “high-intensity” vs. “low-intensity” smoking cessation intervention in active smokers with chronic obstructive pulmonary disease

BACKGROUND: Cigarette smoking is the leading cause of chronic obstructive pulmonary disease (COPD), and it contributes to the development of many other serious diseases. Smoking cessation in COPD patients is known to improve survival and reduce the number of hospitalization-requiring acute exacerbat...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Mohamad Isam, Sivapalan, Pradeesh, Eklöf, Josefin, Ulrik, Charlotte Suppli, Pisinger, Charlotta, Lapperre, Therese, Tønnesen, Philip, Hoyer, Nils, Janner, Julie, Karlsson, Marie Lavesen, Bech, Charlotte Sandau, Marså, Kristoffer, Godtfredsen, Nina, Brøndum, Eva, Munk, Birgit, Raaschou, Merete, Browatzski, Andrea, Lütken, Pernille, Jensen, Jens-Ulrik Stæhr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441548/
https://www.ncbi.nlm.nih.gov/pubmed/32825845
http://dx.doi.org/10.1186/s13063-020-04653-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441548/
https://www.ncbi.nlm.nih.gov/pubmed/32825845
http://dx.doi.org/10.1186/s13063-020-04653-z

Ejemplares similares